Marc Carrier/X
Apr 13, 2026, 12:48
Marc Carrier: The Vermont Model Demonstrates the Power of VTE Prevention
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article by Chris Holmes et al, published in JCO Oncology Practice:
”Real-world evidence confirms what trials have shown: guideline-based VTE prevention matters.
In high-risk ambulatory cancer patients, a multidisciplinary program (‘Vermont model‘) led to:
- VTE: 3.2% vs 7.7% (OR 0.36)
- 6-month mortality: 16.8% vs 31.3% (OR 0.46)
- Despite strong evidence, uptake remains suboptimal, closing this gap is an immediate opportunity to improve outcomes in cancer care.”
Title: Impact of Venous Thrombosis Prevention in Ambulatory Oncology: Importance of Guideline Adherence
Authors: Chris Holmes, Karlyn Martin, Derek Devine, Jacob Barker, Peter Callas, Karen Libby, Emily Parenteau, Mary Cushman, Steven Ades
Read the Full Article on JCO Oncology Practice
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 13, 2026, 13:07Laura Dormer: Real-World Insights into Treatment and Costs in VWD from FORvWARD Study
-
Apr 13, 2026, 13:02CAN-ACT Reaches 200 Patients in Six Months – Loeys-Dietz Syndrome Foundation Canada
-
Apr 13, 2026, 12:45Fonkou Steve: Building a Trusted Community of Voluntary Blood Donors
-
Apr 13, 2026, 12:37Megan Adediran: Diagnosis Is the First Step to Care
-
Apr 13, 2026, 12:32Ilenia Calcaterra: Study on Platelet TF–TFPI Imbalance in Hemophilia A Accepted at ISTH 2026
-
Apr 13, 2026, 12:19David Montani: How to Treat Pulmonary Embolism Catheter or Standard Therapy
-
Apr 13, 2026, 12:17Tareq Abadl: Irradiated Blood – Safer, Not More Dangerous
-
Apr 13, 2026, 12:11Chokri Ben Lamine: Thread Platelet Subpopulations Leads to Therapeutic Implications
-
Apr 13, 2026, 11:49Jecko Thachil: Why Splenectomy Increases Thrombosis Risk and How We Can Prevent It